Tag Archives: Qnexa
Avanafil Passes Second Late-Stage Test
Vivus (VVUS) shares had a bounce this morning by the encouraging announcement of round two of late-stage data on avanafil, a erectile dysfunction drug. Within 15 minutes of two doses, avanafil showed significant improvements of erectile function and intercourse from … Continue reading
New weight loss pill promises to fight high blood pressure, diabetes
by JEAN ENERSEN / KING 5 News Posted on May 19, 2010 at 5:45 PM Excessive weight gain isn’t only unhealthy, it’s expensive. Nearly 10 percent of U.S. healthcare dollars are spent on obesity-related expenses. That’s why there’s so much … Continue reading
Motley Fool lists VIVUS as 1 of 5 Stocks Breaking Out
Excerpt from Motley Fool Article VIVUS has a lot riding on its obesity drug Qnexa, which has potentially huge profit potential due to the size (sorry) of its target market. Along with competitor Arena Pharmaceuticals (Nasdaq: ARNA) — who is … Continue reading
VIVUS Reports First Quarter 2010 Financial Results
// // // ]]> MOUNTAIN VIEW, Calif., May 3, 2010 /PRNewswire via COMTEX/ — VIVUS, Inc. (10.71, -0.04, -0.37%), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its highlights and financial results for the first quarter … Continue reading